common.study.topics.clinical

Contraceptive Vaginal Ring

common.study.values.description

Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring

This will be a multi-site, open-label, randomized clinical trial. The investigators will randomize 300 eligible participants in a 1:1 ratio to two different treatment regimens that are to be followed when using a contraceptive vaginal ring delivering a daily dose of NestoroneAR and estradiol (NES-E2 CVR).

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - NES-E2 CVR

NES-E2 CVR

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Multicenter, Open-label Randomized Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of Nestorone® and Estradiol (NES-E2 CVR).

common.study.values.clinical-trial-id

NCT03432416

participant.views.study.view.id

vbmrnd